cGVHD

Pediatric Oncology Belumosudil is effective in Pediatric Patients with chronic Graft-versus-Host disease after failed Ruxolitinib treatment
Yuanyuan Chen • Xiaojun Xu • Fenfen Jin
doi.org/10.69690/ODMJ-018-0425-2454